AbbVie Inc. Comprehensive Income
AbbVie Inc. (ABBV) reported Comprehensive Income of $3.61 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-03
- AbbVie Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $3.61B, a 215.94% increase year-over-year.
- AbbVie Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $686.00M, a 53.30% decline year-over-year.
- AbbVie Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $2.25B, a 480.36% increase year-over-year.
- AbbVie Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $150.00M, a 91.38% decline year-over-year.
- AbbVie Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $5.01B, a 7.49% increase from fiscal 2024.
- AbbVie Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $4.66B, a 2.08% decline from fiscal 2023.
- AbbVie Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $4.76B, a 62.05% decline from fiscal 2022.
- AbbVie Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $12.54B, a 6.60% increase from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.61B 10-Q · filed 2026-08-03 | $4.29B 10-Q · filed 2026-08-03 | $6.54B derived: sum of 3 quarters · filed 2026-08-03 | $6.69B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $686.00M 10-Q · filed 2026-05-08 | $2.93B derived: sum of 2 quarters · filed 2026-05-08 | $3.08B derived: sum of 3 quarters · filed 2026-05-08 | $4.22B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $2.25B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $2.40B derived: sum of 2 quarters · filed 2026-02-20 | $3.54B derived: sum of 3 quarters · filed 2026-08-03 | $5.01B 10-K · filed 2026-02-20 |
| 2025-09-30 | $150.00M 10-Q · filed 2025-11-04 | $1.29B derived: sum of 2 quarters · filed 2026-08-03 | $2.76B 10-Q · filed 2025-11-04 | $3.15B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $1.14B 10-Q · filed 2026-08-03 | $2.61B 10-Q · filed 2026-08-03 | $3.00B derived: sum of 3 quarters · filed 2026-08-03 | $4.74B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $1.47B 10-Q · filed 2026-05-08 | $1.86B derived: sum of 2 quarters · filed 2026-05-08 | $3.60B derived: sum of 3 quarters · filed 2026-05-08 | $4.91B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $387.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $2.13B derived: sum of 2 quarters · filed 2026-02-20 | $3.44B derived: sum of 3 quarters · filed 2026-02-20 | $4.66B 10-K · filed 2026-02-20 |
| 2024-09-30 | $1.74B 10-Q · filed 2025-11-04 | $3.05B derived: sum of 2 quarters · filed 2025-11-04 | $4.27B 10-Q · filed 2025-11-04 | $5.14B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $1.31B 10-Q · filed 2025-08-04 | $2.53B 10-Q · filed 2025-08-04 | $3.40B derived: sum of 3 quarters · filed 2026-02-20 | $5.08B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $1.22B 10-Q · filed 2025-05-09 | $2.09B derived: sum of 2 quarters · filed 2026-02-20 | $3.77B derived: sum of 3 quarters · filed 2026-02-20 | $5.77B derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $870.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $2.55B derived: sum of 2 quarters · filed 2026-02-20 | $4.55B derived: sum of 3 quarters · filed 2026-02-20 | $4.76B 10-K · filed 2026-02-20 |
| 2023-09-30 | $1.68B 10-Q · filed 2024-11-04 | $3.68B derived: sum of 2 quarters · filed 2024-11-04 | $3.89B 10-Q · filed 2024-11-04 | $7.60B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $2.00B 10-Q · filed 2024-08-07 | $2.21B 10-Q · filed 2024-08-07 | $5.93B derived: sum of 3 quarters · filed 2025-02-14 | $9.63B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $206.00M 10-Q · filed 2024-05-03 | $3.92B derived: sum of 2 quarters · filed 2025-02-14 | $7.63B derived: sum of 3 quarters · filed 2025-02-14 | $8.34B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $3.72B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $7.42B derived: sum of 2 quarters · filed 2025-02-14 | $8.13B derived: sum of 3 quarters · filed 2025-02-14 | $12.54B 10-K · filed 2025-02-14 |
| 2022-09-30 | $3.70B 10-Q · filed 2023-11-06 | $4.41B derived: sum of 2 quarters · filed 2023-11-06 | $8.82B 10-Q · filed 2023-11-06 | $13.12B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $712.00M 10-Q · filed 2023-08-07 | $5.12B 10-Q · filed 2023-08-07 | $9.42B derived: sum of 3 quarters · filed 2024-02-20 | $12.54B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $4.41B 10-Q · filed 2023-05-05 | $8.71B derived: sum of 2 quarters · filed 2024-02-20 | $11.83B derived: sum of 3 quarters · filed 2024-02-20 | $12.79B derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $4.30B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $7.43B derived: sum of 2 quarters · filed 2024-02-20 | $8.38B derived: sum of 3 quarters · filed 2024-02-20 | $11.76B 10-K · filed 2024-02-20 |
| 2021-09-30 | $3.13B 10-Q · filed 2022-11-04 | $4.08B derived: sum of 2 quarters · filed 2022-11-04 | $7.46B 10-Q · filed 2022-11-04 | $7.64B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $958.00M 10-Q · filed 2022-08-04 | $4.33B 10-Q · filed 2022-08-04 | $4.51B derived: sum of 3 quarters · filed 2023-02-17 | $7.00B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $3.38B 10-Q · filed 2022-05-06 | $3.55B derived: sum of 2 quarters · filed 2023-02-17 | $6.04B derived: sum of 3 quarters · filed 2023-02-17 | $5.56B derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $178.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $2.66B derived: sum of 2 quarters · filed 2023-02-17 | $2.19B derived: sum of 3 quarters · filed 2023-02-17 | $5.09B 10-K · filed 2023-02-17 |
| 2020-09-30 | $2.48B 10-Q · filed 2021-11-02 | $2.01B derived: sum of 2 quarters · filed 2021-11-02 | $4.92B 10-Q · filed 2021-11-02 | $6.65B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | -$476.00M 10-Q · filed 2021-08-02 | $2.43B 10-Q · filed 2021-08-02 | $4.17B derived: sum of 3 quarters · filed 2022-02-18 | $6.01B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $2.91B 10-Q · filed 2021-05-07 | $4.64B derived: sum of 2 quarters · filed 2022-02-18 | $6.49B derived: sum of 3 quarters · filed 2022-02-18 | $7.25B derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $1.73B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $3.58B derived: sum of 2 quarters · filed 2022-02-18 | $4.35B derived: sum of 3 quarters · filed 2022-02-18 | $6.77B 10-K · filed 2022-02-18 |
| 2019-09-30 | $1.85B 10-Q · filed 2020-11-04 | $2.61B derived: sum of 2 quarters · filed 2020-11-04 | $5.03B 10-Q · filed 2020-11-04 | $3.29B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $766.00M 10-Q · filed 2020-08-04 | $3.19B 10-Q · filed 2020-08-04 | $1.44B derived: sum of 3 quarters · filed 2021-02-19 | $4.27B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $2.42B 10-Q · filed 2020-05-08 | $673.00M derived: sum of 2 quarters · filed 2021-02-19 | $3.50B derived: sum of 3 quarters · filed 2021-02-19 | $5.47B derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | -$1.75B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $1.08B derived: sum of 2 quarters · filed 2021-02-19 | $3.05B derived: sum of 3 quarters · filed 2021-02-19 | $5.93B 10-K · filed 2021-02-19 |
| 2018-09-30 | $2.83B 10-Q · filed 2019-11-06 | $4.80B derived: sum of 2 quarters · filed 2019-11-06 | $7.68B 10-Q · filed 2019-11-06 | $7.62B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $1.97B 10-Q · filed 2019-08-05 | $4.85B 10-Q · filed 2019-08-05 | $4.79B derived: sum of 3 quarters · filed 2020-02-21 | $6.36B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $2.88B 10-Q · filed 2019-05-03 | $2.82B derived: sum of 2 quarters · filed 2020-02-21 | $4.38B derived: sum of 3 quarters · filed 2020-02-21 | $6.29B derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $1.50B derived: sum of 2 quarters · filed 2020-02-21 | $3.41B derived: sum of 3 quarters · filed 2020-02-21 | $5.17B 10-K · filed 2020-02-21 |
| 2017-09-30 | $1.57B 10-Q · filed 2018-11-07 | $3.48B derived: sum of 2 quarters · filed 2018-11-07 | $5.23B 10-Q · filed 2018-11-07 | $6.38B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $1.91B 10-Q · filed 2018-08-07 | $3.66B 10-Q · filed 2018-08-07 | $4.81B derived: sum of 3 quarters · filed 2019-02-27 | $6.46B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $1.75B 10-Q · filed 2018-05-04 | $2.90B derived: sum of 2 quarters · filed 2019-02-27 | $4.55B derived: sum of 3 quarters · filed 2019-02-27 | $6.19B derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $1.15B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.79B derived: sum of 2 quarters · filed 2019-02-27 | $4.44B derived: sum of 3 quarters · filed 2019-02-27 | $5.93B 10-K · filed 2019-02-27 |
| 2016-09-30 | $1.65B 10-Q · filed 2017-11-07 | $3.29B derived: sum of 2 quarters · filed 2017-11-07 | $4.78B 10-Q · filed 2017-11-07 | $6.24B derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $1.64B 10-Q · filed 2017-08-07 | $3.13B 10-Q · filed 2017-08-07 | $4.59B derived: sum of 3 quarters · filed 2018-02-16 | $5.70B derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $1.49B 10-Q · filed 2017-05-05 | $2.95B derived: sum of 2 quarters · filed 2018-02-16 | $4.06B derived: sum of 3 quarters · filed 2018-02-16 | $5.52B derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $1.46B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $2.57B derived: sum of 2 quarters · filed 2018-02-16 | $4.03B derived: sum of 3 quarters · filed 2018-02-16 | $4.61B 10-K · filed 2018-02-16 |
| 2015-09-30 | $1.11B 10-Q · filed 2016-11-07 | $2.57B derived: sum of 2 quarters · filed 2016-11-07 | $3.16B 10-Q · filed 2016-11-07 | $1.23B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $1.46B 10-Q · filed 2016-08-05 | $2.04B 10-Q · filed 2016-08-05 | $117.00M derived: sum of 3 quarters · filed 2017-02-17 | $130.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $586.00M 10-Q · filed 2016-05-06 | -$1.34B derived: sum of 2 quarters · filed 2017-02-17 | -$1.33B derived: sum of 3 quarters · filed 2017-02-17 | -$225.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | -$1.93B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$1.92B derived: sum of 2 quarters · filed 2017-02-17 | -$811.00M derived: sum of 3 quarters · filed 2017-02-17 | $185.00M 10-K · filed 2017-02-17 |
| 2014-09-30 | $13.00M 10-Q · filed 2015-11-06 | $1.12B derived: sum of 2 quarters · filed 2015-11-06 | $2.11B 10-Q · filed 2015-11-06 | $3.76B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $1.10B 10-Q · filed 2015-08-07 | $2.10B 10-Q · filed 2015-08-07 | $3.75B derived: sum of 3 quarters · filed 2016-02-19 | $4.90B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $996.00M 10-Q · filed 2015-05-08 | $2.64B derived: sum of 2 quarters · filed 2016-02-19 | $3.79B derived: sum of 3 quarters · filed 2016-02-19 | $4.93B derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $1.65B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $2.80B derived: sum of 2 quarters · filed 2016-02-19 | $3.94B derived: sum of 3 quarters · filed 2016-02-19 | $4.70B 10-K · filed 2016-02-19 |
| 2013-09-30 | $1.15B 10-Q · filed 2014-11-07 | $2.29B derived: sum of 2 quarters · filed 2014-11-07 | $3.05B 10-Q · filed 2014-11-07 | $4.58B derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-06-30 | $1.14B 10-Q · filed 2014-08-07 | $1.90B 10-Q · filed 2014-08-07 | $3.43B derived: sum of 3 quarters · filed 2015-02-20 | $5.29B derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | $763.00M 10-Q · filed 2014-05-09 | $2.29B derived: sum of 2 quarters · filed 2015-02-20 | $4.16B derived: sum of 3 quarters · filed 2015-02-20 | $4.91B derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | $1.53B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $3.40B derived: sum of 2 quarters · filed 2015-02-20 | $4.14B derived: sum of 3 quarters · filed 2015-02-20 | $5.25B 10-K · filed 2015-02-20 |
| 2012-09-30 | $1.87B 10-Q · filed 2013-11-12 | $2.61B derived: sum of 2 quarters · filed 2013-11-12 | $3.72B 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $747.00M 10-Q · filed 2013-08-09 | $1.85B 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $1.10B 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $3.12B 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |